Cancer Immunotherapy Using Gene-Modified Dendritic Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|2|1|57-78

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.2, Iss.1, 2002-02, pp. : 57-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically Modified Dendritic Cells for Cancer Immunotherapy

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 619-628

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells: Activation and Maturation - Applications for Cancer Immunotherapy

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1783-1800

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Responses to Gene-Modified T Cells

By  

Current Gene Therapy, Vol. 7, Iss. 5, 2007-10 ,pp. : 361-368

Bentham Science Publishers

Access to resources Recommend Favorite

Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine Gene Transfer into Dendritic Cells for Cancer Treatment

By  

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 79-89

Bentham Science Publishers

Access to resources Recommend Favorite